These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19358839)

  • 21. Voluntary oral feeding of rats not requiring a very high fat diet is a clinically relevant animal model of non-alcoholic fatty liver disease (NAFLD).
    Tipoe GL; Ho CT; Liong EC; Leung TM; Lau TY; Fung ML; Nanji AA
    Histol Histopathol; 2009 Sep; 24(9):1161-9. PubMed ID: 19609863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preventive effects of citrulline on Western diet-induced non-alcoholic fatty liver disease in rats.
    Jegatheesan P; Beutheu S; Freese K; Waligora-Dupriet AJ; Nubret E; Butel MJ; Bergheim I; De Bandt JP
    Br J Nutr; 2016 Jul; 116(2):191-203. PubMed ID: 27197843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of dietary fat to produce non-alcoholic fatty liver in the rat.
    Ahmed U; Redgrave TG; Oates PS
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1463-71. PubMed ID: 19702912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obstructive cholestasis induces TNF-alpha- and IL-1 -mediated periportal downregulation of Bsep and zonal regulation of Ntcp, Oatp1a4, and Oatp1b2.
    Donner MG; Schumacher S; Warskulat U; Heinemann J; Häussinger D
    Am J Physiol Gastrointest Liver Physiol; 2007 Dec; 293(6):G1134-46. PubMed ID: 17916651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased hepatic apoptosis in high-fat diet-induced NASH in rats may be associated with downregulation of hepatic stimulator substance.
    Jiang Y; Zhao M; An W
    J Mol Med (Berl); 2011 Dec; 89(12):1207-17. PubMed ID: 21814826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of bile salt and organic anion transporters in developing rat liver.
    Gao B; St Pierre MV; Stieger B; Meier PJ
    J Hepatol; 2004 Aug; 41(2):201-8. PubMed ID: 15288467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered regulation of hepatic efflux transporters disrupts acetaminophen disposition in pediatric nonalcoholic steatohepatitis.
    Canet MJ; Merrell MD; Hardwick RN; Bataille AM; Campion SN; Ferreira DW; Xanthakos SA; Manautou JE; A-Kader HH; Erickson RP; Cherrington NJ
    Drug Metab Dispos; 2015 Jun; 43(6):829-35. PubMed ID: 25788542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of mouse organic anion-transporting polypeptides (Oatps) in liver by prototypical microsomal enzyme inducers that activate distinct transcription factor pathways.
    Cheng X; Maher J; Dieter MZ; Klaassen CD
    Drug Metab Dispos; 2005 Sep; 33(9):1276-82. PubMed ID: 15919853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of G protein-coupled receptor kinase 2 (GRK2) in the development of non-alcoholic steatosis and steatohepatitis in mice and humans.
    Cruces-Sande M; Vila-Bedmar R; Arcones AC; González-Rodríguez Á; Rada P; Gutiérrez-de-Juan V; Vargas-Castrillón J; Iruzubieta P; Sánchez-González C; Formentini L; Crespo J; García-Monzón C; Martínez-Chantar ML; Valverde ÁM; Mayor F; Murga C
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3655-3667. PubMed ID: 30261289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic expression of hepatic thioredoxin mRNA in rats with non-alcoholic fatty liver disease.
    Duan XY; Zhao HP; Fan JG
    J Dig Dis; 2010 Apr; 11(2):94-100. PubMed ID: 20402835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of probiotics on methionine choline deficient diet-induced steatohepatitis in rats.
    Karahan N; Işler M; Koyu A; Karahan AG; Başyığıt Kiliç G; Cırış IM; Sütçü R; Onaran I; Cam H; Keskın M
    Turk J Gastroenterol; 2012 Apr; 23(2):110-21. PubMed ID: 22706738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered Expression and Function of Hepatic Transporters in a Rodent Model of Polycystic Kidney Disease.
    Bezençon J; Beaudoin JJ; Ito K; Fu D; Roth SE; Brock WJ; Brouwer KLR
    Drug Metab Dispos; 2019 Aug; 47(8):899-906. PubMed ID: 31160314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis.
    Linden MA; Sheldon RD; Meers GM; Ortinau LC; Morris EM; Booth FW; Kanaley JA; Vieira-Potter VJ; Sowers JR; Ibdah JA; Thyfault JP; Laughlin MH; Rector RS
    J Physiol; 2016 Sep; 594(18):5271-84. PubMed ID: 27104887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-fat emulsion-induced rat model of nonalcoholic steatohepatitis.
    Zou Y; Li J; Lu C; Wang J; Ge J; Huang Y; Zhang L; Wang Y
    Life Sci; 2006 Aug; 79(11):1100-7. PubMed ID: 16624332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mechanism of hepatocyte apoptosis in rats with liver fibrosis induced by lipogenic methionine-choline-deficient diet].
    Mu YP; Ogawa T; Kwada N
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):112-8. PubMed ID: 22455888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential regulation of hepatic transporters in the absence of tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and nuclear factor-kappaB in two models of cholestasis.
    Lickteig AJ; Slitt AL; Arkan MC; Karin M; Cherrington NJ
    Drug Metab Dispos; 2007 Mar; 35(3):402-9. PubMed ID: 17151194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Signal transduction mechanism of TRB3 in rats with non-alcoholic fatty liver disease.
    Wang YG; Shi M; Wang T; Shi T; Wei J; Wang N; Chen XM
    World J Gastroenterol; 2009 May; 15(19):2329-35. PubMed ID: 19452573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genes of the antioxidant response undergo upregulation in a rodent model of nonalcoholic steatohepatitis.
    Lickteig AJ; Fisher CD; Augustine LM; Cherrington NJ
    J Biochem Mol Toxicol; 2007; 21(4):216-20. PubMed ID: 17721935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sweroside Prevents Non-Alcoholic Steatohepatitis by Suppressing Activation of the NLRP3 Inflammasome.
    Yang G; Jang JH; Kim SW; Han SH; Ma KH; Jang JK; Kang HC; Cho YY; Lee HS; Lee JY
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.